ST-246 Approval Status
- FDA approved: No
- Brand name: ST-246
- Company: SIGA Technologies, Inc.
- Treatment for: Exposure to Smallpox Virus
ST-246 is an orally active, smallpox antiviral in development to treat individuals exposed to the smallpox virus in the event of an outbreak.
FDA Approval Status for ST-246
|Apr 4, 2008||SIGA Initiates Manufacture of ST-246 NDA Registration Batches|
|Mar 24, 2008||SIGA Files Application Supporting Emergency Use Approval for ST-246|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.